BG Medicine, Inc.
BGMD
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Revenue | -47.65% | -51.94% | -36.80% | -40.87% | -51.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -47.65% | -51.94% | -36.80% | -40.87% | -51.78% |
| Cost of Revenue | -57.29% | -55.98% | -38.79% | -39.92% | -38.06% |
| Gross Profit | -42.54% | -49.89% | -35.71% | -41.34% | -56.85% |
| SG&A Expenses | -37.29% | -45.45% | -33.19% | -43.50% | -55.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.81% | -46.12% | -29.60% | -36.97% | -37.19% |
| Operating Income | 30.39% | 43.90% | 26.69% | 35.49% | 27.09% |
| Income Before Tax | 31.67% | 57.32% | 6.45% | 38.14% | 31.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.67% | 57.32% | 6.45% | 38.14% | 31.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.67% | 57.32% | 6.45% | 38.14% | 31.78% |
| EBIT | 30.39% | 43.90% | 26.69% | 35.49% | 27.09% |
| EBITDA | 30.08% | 43.82% | 26.59% | 35.89% | 27.15% |
| EPS Basic | 44.81% | 4.38% | 8.37% | 50.00% | 44.68% |
| Normalized Basic EPS | 47.49% | 55.25% | 8.38% | 50.00% | 44.69% |
| EPS Diluted | 44.81% | 4.38% | 8.37% | 50.00% | 44.68% |
| Normalized Diluted EPS | 47.49% | 55.25% | 8.38% | 50.00% | 44.69% |
| Average Basic Shares Outstanding | 30.77% | 14.63% | 2.11% | 23.71% | 23.37% |
| Average Diluted Shares Outstanding | 30.77% | 14.63% | 2.11% | 23.71% | 23.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
